Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Tatyana I Ionova, PhD, Tatiana P Nikitina, PhD, Taras A Gritsenko, MD, PhD, Valentina L Ivanova, MD, PhD, Galina B Kuchma, MD, PhD, Tatyana V Shnaider, MD, PhD, Denis A Fedorenko, MD, PhD, Kira A Kurbatova, Andrei A Novik, MD, PhD

Blood (2012) 120 (21): 4445.

https://doi.org/10.1182/blood.V120.21.4445.4445

Published: 2012

Journal Articles

Reduced Intensity Conditioning Regimen of Autologous Hematopoietic Stem Cell Transplantation±Mitoxantrone Consolidation In Multiple Sclerosis

Andrei A Novik, Aleksey N Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrei V Kartashov, Tatyana I Ionova, Kira A Kurbatova, Gary I Gorodokin

Blood (2010) 116 (21): 372.

https://doi.org/10.1182/blood.V116.21.372.372

Published: 2010

Journal Articles

The Utility of the New Instrument for Comprehensive Symptom Profile Assessment In Patients with Multiple Myeloma

Andrei A Novik, Tatyana I Ionova, Svetlana A Kalyadina, Denis A Fedorenko, Nikita E Mochkin, Kira A Kurbatova, Tatyana P Nikitina, Gary I Gorodokin

Blood (2010) 116 (21): 4757.

https://doi.org/10.1182/blood.V116.21.4757.4757

Published: 2010

Journal Articles

New Instrument for Comprehensive Symptom Profile Assessment In Patients with Malignant Lymphomas

Andrei A Novik, Tatyana I Ionova, Svetlana A Kalyadina, Denis A Fedorenko, Nikita E Mochkin, Kira A Kurbatova, Tatyana P Nikitina, Gary I Gorodokin

Blood (2010) 116 (21): 2561.

https://doi.org/10.1182/blood.V116.21.2561.2561

Published: 2010

Journal Articles

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Andrei A. Novik, MD, FRCP, Alexey N. Kuznetsov, Vladimir Y Melnichenko, Denis A Fedorenko, Andrey Kartashov, Ruslana V Kruglina, Tatiana I Ionova, Kira Kurbatova, Gary J Gorodokin

Blood (2009) 114 (22): 2317.

https://doi.org/10.1182/blood.V114.22.2317.2317

Published: 2009

Journal Articles

Mini-Autologous Hematopoietic Stem Cell Transplantations as a New Treatment Modality for Multiple Sclerosis Patients

Andrei A Novik, Vladimir Y Melnichenko, Denis A Fedorenko, Ruslana V Kruglina, Tatiana I Ionova, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin

Blood (2008) 112 (11): 4454.

https://doi.org/10.1182/blood.V112.11.4454.4454

Published: 2008

Journal Articles

Four Strategies of Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Treatment

Andrei A. Novik, MD, FRCP, Boris V Afanasyev, Igor A Lisukov, Oleg A Rykavicin, Alexandr A Myasnikov, Tatiana I Ionova, Vladimir Y Melnichenko, Denis A Fedorenko, Nina E Osipova, Artur E Zdorov, Ruslana V Kruglina, Anton V Kishtovich, Roman I Ivanov, Gary J Gorodokin

Blood (2008) 112 (11): 4432.

https://doi.org/10.1182/blood.V112.11.4432.4432

Published: 2008

Journal Articles

Which Strategy of Immunoablative Therapy with Autologous Stem Cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.

Yury L. Shevchenko, Andrei A. Novik, Alexey N. Kuznetcov, Boris A. Afanasiev, Igor A. Lisukov, Oleg A. Rykavicin, Alexandr A. Myasnikov, Tatyana I. Ionova, PhD, Vladimir J. Melnichenko, MD, PhD, Denis A. Fedorenko, MD, PhD, Anton V. Kishtovich, PhD, Roman A. Ivanov, PhD, Gary J. Gorodokin, MD

Blood (2007) 110 (11): 5093.

https://doi.org/10.1182/blood.V110.11.5093.5093

Published: 2007

Journal Articles

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Blood (2006) 108 (11): 3072.

https://doi.org/10.1182/blood.V108.11.3072.3072

Published: 2006

Journal Articles

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Yury L. Shevchenko, Andrei A. Novik, Boris V. Afanasiev, Igor A. Lisukov, Tatiana I. Ionova, PhD, Andrei D. Kulagin, MD, Olga A. Malysheva, MD, Gennady N. Bisaga, MD, PhD, Vladimir J. Melnichenko, MD, PhD, Sergei V. Voloshin, MD, PhD, Denis A. Fedorenko, MD, PhD, Inna V. Vereschagina, MD, Anton V. Kishtovich, PhD, Yury N. Fedotov, MD, PhD, Gary I. Gorodokin, MD

Blood (2005) 106 (11): 5467.

https://doi.org/10.1182/blood.V106.11.5467.5467

Published: 2005

Journal Articles

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Andrei A. Novik, Tatiana I. Ionova, PhD, Anton V. Kishtovich, PhD, Alexander A. Myasnikov, Tatiana V. Chagorova, MD, PhD, Mikhail V. Kopp, Nina E. Osipova, MD, Julia K. Lebedeva, MD, Natalia N. Malakchova, MD, Anastasia V. Pankova, Denis A. Fedorenko, MD, PhD, Gary I. Gorodokin, MD

Blood (2005) 106 (11): 4651.

https://doi.org/10.1182/blood.V106.11.4651.4651

Published: 2005

NARROW

Clinical and Patient-Reported Outcomes of Dasatinib Therapy in Patients with Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Reduced Intensity Conditioning Regimen of Autologous Hematopoietic Stem Cell Transplantation±Mitoxantrone Consolidation In Multiple Sclerosis

The Utility of the New Instrument for Comprehensive Symptom Profile Assessment In Patients with Multiple Myeloma

New Instrument for Comprehensive Symptom Profile Assessment In Patients with Malignant Lymphomas

Reduced Intensity Conditioning Regimens in Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis patients.

Mini-Autologous Hematopoietic Stem Cell Transplantations as a New Treatment Modality for Multiple Sclerosis Patients

Four Strategies of Autologous Hematopoietic Stem Cell Transplantation for Multiple Sclerosis Treatment

Which Strategy of Immunoablative Therapy with Autologous Stem Cell Transplantation (ASCT) Is Preferable in Multiple Sclerosis (MS) Patients?.

Multicenter Experience of High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT) in Multiple Sclerosis (MS) Patients.

Treatment Outcomes in Multiple Sclerosis (MS) Patients after Early, Conventional and Salvage High Dose Chemotherapy (HDCT)+Autologous Stem Cell Transplantation (ASCT).

Quality of Life (QoL) Impairment and International Prognostic Index (IPI) in New Aggressive Non-Hodgkin’s Lymphoma (ANHL) Patients.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only